Funded VALIDATE Fellowships

VALIDATE Fellows

VALIDATE Fellowships are competitively awarded to excellent Early Career Researcher (Associate) Members to fund two years' independent scientific research with the aim of producing initial/pilot data, and a funding and experience track record, that can be used by the Fellow to go on to obtain independent external funding and launch their career as a Principal Investigator and/or Group Leader. Find out more about our VALIDATE Fellows and their research below.

 

2025- 2027

 

Camila Freitas

Dr Camila Freitas

Federal University of Minas Gerais (UFMG), Brazil

Preclinical evaluation of a novel recombinant chimeric vaccine for protection against tegumentary 
leishmaniasis

 

Project Details

 

 

Mariano Maio

Dr Mariano Maio

Instituto de Investigaciones Biomedicas en Retrovirus y Sida (INBIRS), Argentina 

Boosting BCG Vaccine Efficacy through Metabolic Modulation of T Memory stem Cells: Implications for Mycobacterium tuberculosis Protection

 

Project details

 

Monika Looney

Dr Monika Looney

South African Tuberculosis Vaccine Initiative, University of Cape Town (SATVI, 
UCT), South Africa 

Pilot study to investigate tissue-based immunological profiles associated with TB with 
single-cell spatial resolution in human lymph nodes

Project details

 

Robert Krause

Dr Robert Krause 

Division of Molecular Biology and Human Genetics, Stellenbosch University, South Africa 

Measuring the immunogenicity and efficacy of a novel DNA-launched therapeutic for tuberculosis 
in both murine and human models

Project details

 

 

Zimvo Obasa

Dr Zimvo Obasa 

Division of Molecular Biology and Human Genetics, Stellenbosch University, South Africa 

Evaluating the Immunogenicity and Efficacy of Curdlan-PLGA Nanoparticles Encapsulating 
Mycobacterium tuberculosis Antigens

Project details

 

 

 

2024 - 2026

Susana Flores Villalva

Dr Susana Flores Villalva

Instituto Nacional de Investigaciones Forestales Agrícolas y Pecuarias (INIFAP), Mexico

Elucidating the microbicidal and regulatory functions of bovine neutrophils during a natural Mycobacterium bovis infection

 

Project Details

 

 

Paula Niewold

Dr Paula Niewold

Leiden University Medical Center (LUMC), Netherlands

Translating protective immune signatures in the lung to peripheral biomarkers for TB
 

Project Details

 

 

Paniela Pagliara

Dr Daniela Pagliara Lage

Federal University of Minas Gerais (FUMG), Brazil

Evaluation of a recombinant chimeric protein vaccine with adjuvant for the protection against visceral leishmaniasis
 

Project Details

 

 

Thao-Thy Pham

Dr Thao-Thy Pham

Institute of Tropical Medicine Antwerp, Belgium

Establishing the immunogenicity of the first naturally presented Leishmania epitope vaccine candidates in Ethiopian cutaneous leishmaniasis
 

Project Details

 

Elena Stylianou

Dr Elena Stylianou

University of Oxford, UK

Defining the mechanism of BCG-priming and its impact on subunit vaccine boosting

 

Project Details

 

 

Happy Tshivhula

Dr Happy Tshivhula

Stellenbosch University, South Africa

Probing extreme phenotypes to determine correlates of risk for recurrent TB: a step towards optimised vaccine development

 

Project details

 

 

2022-2024

Nastassja Kriel

 

Dr Nastassja Kriel

Stellenbosch University, South Africa

Identifying persister Mycobacterium tuberculosis biosignatures

Project Details

 

Cristian Segura-Cerda

Dr Cristian Segura-Cerda

CIATEJ, Mexico

Evaluation of the efficacy of BCGΔBCG1419c vaccination plus a booster of EsxG/EsxH-derived peptides to prevent tuberculosis progression caused by Mycobacterium tuberculosis strains prevalent in Latin America

Project Details

 

 

2018-2021

Jomien Mouton

 

Dr Jomien Mouton

Stellenbosch University, South Africa

Identification of latency associated antigens and biosignatures associated with Mycobacterium tuberculosis

Project Details

 

Rachel Tanner

 

Dr Rachel Tanner

University of Oxford, UK

Characterising the BCG-induced antibody response to inform the design of improved vaccines against M.tuberculosis, M.leprae and M.bovis

Project Details